To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TPM4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
504 representative clones for gene TPM4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC303303 cerebellum .a 1 to 517 1 to 519   tiling clone,   519/519
(100 %)
4 diff
(99.3 %id)
BG703258 brain, hippocampus .a 13 to 643 1 to 627       627/627
(100 %)
9 diff
(98.6 %id)
DC365500   .a 19 to 419 1 to 401   tiling clone,   401/401
(100 %)
1 diff
(99.8 %id)
NM_003290.2   .a 20 to 2664 1 to 2645   RefSeq,   2645/2645
(100 %)
0 diff
(100 %id)
DC391570 Spleen .a 102 to 408 1 to 307       307/307
(100 %)
0 diff
(100 %id)
BM455660 lymph, lymphoma, cell line .a 151 to 1095 1 to 962       960/1047
(91 %)
28 diff
(97.4 %id)
BC037576 Eye, retinoblastoma .a 153 to 1845 9 to 1701   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1693/1693
(100 %)
0 diff
(100 %id)
BQ216067 embryonal carcinoma, cell line, testis .a 157 to 1055 1 to 914       912/919
(99 %)
19 diff
(98.0 %id)
DB019090 esophageal, tumor tissue .a 157 to 622 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
DA478145   .a 158 to 730 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA610030   .a 160 to 726 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA849275 placenta .a 160 to 619 2 to 461   capped   460/460
(100 %)
1 diff
(99.8 %id)
DA573374   .a 161 to 923 2 to 765   capped   764/774
(98 %)
7 diff
(99.1 %id)
AU099278   .a 161 to 460 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
BP254551 Kidney .a 161 to 742 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA842821 placenta .a 162 to 729 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
BM833570 stomach .a 162 to 562 1 to 401       401/401
(100 %)
2 diff
(99.6 %id)
BM849876 myeloma .a 162 to 596 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
DA375345 thalamus .a 163 to 707 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA379946 thalamus .a 163 to 775 2 to 614   capped   613/613
(100 %)
1 diff
(99.9 %id)
DA380289 thalamus .a 163 to 720 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AU104987   .a 163 to 212 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP207425 coronary artery .a 163 to 746 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
DA506574 brain .a 163 to 736 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA544275   .a 163 to 726 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP235597 coronary artery .a 163 to 758 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
DA590085 lung .a 163 to 723 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA601875   .a 163 to 727 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA687161   .a 163 to 411 2 to 250   capped   249/249
(100 %)
0 diff
(100 %id)
AU132283   .a 163 to 948 2 to 788   capped   787/792
(99 %)
6 diff
(99.3 %id)
BM847270 myeloma .a 163 to 710 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DA910039   .a 163 to 736 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA913282   .a 163 to 723 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB007256 cervix, tumor tissue .a 163 to 727 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB008108 cervix, tumor tissue .a 163 to 670 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DA042306 bladder .a 164 to 549 2 to 387   capped   386/386
(100 %)
0 diff
(100 %id)
DA421614 cervix .a 164 to 731 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA596058   .a 164 to 622 2 to 460   capped   459/459
(100 %)
2 diff
(99.6 %id)
DA644238   .a 164 to 727 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA683692   .a 164 to 638 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
DA701596   .a 164 to 638 2 to 476   capped   475/475
(100 %)
1 diff
(99.8 %id)
DA713767   .a 164 to 703 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA907699   .a 164 to 898 2 to 736   capped   735/735
(100 %)
8 diff
(99.0 %id)
DA943813 Spleen .a 164 to 477 2 to 315   capped   314/314
(100 %)
1 diff
(99.7 %id)
DB192966 ovary, tumor tissue .a 164 to 718 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA698246   .a 166 to 622 10 to 467   capped   458/458
(100 %)
1 diff
(99.8 %id)
TI_57187827   .a 170 to 772 46 to 648       603/648
(93 %)
9 diff
(98.7 %id)
CN275215 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 171 to 791 13 to 633       621/633
(98 %)
6 diff
(99.1 %id)
CN275222 embryonic stem cells, DMSO-treated H9 cellline .a 172 to 603 1 to 432       432/432
(100 %)
1 diff
(99.8 %id)
BQ438234 melanotic melanoma, skin .a 176 to 999 1 to 827       827/828
(99 %)
4 diff
(99.6 %id)
CX753030 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 176 to 866 1 to 691     Submitted on the opposite strand 691/692
(99 %)
11 diff
(98.5 %id)
BM801663 duodenal adenocarcinoma, cell line, small intestine .a 177 to 1068 1 to 906       906/924
(98 %)
23 diff
(97.6 %id)
DR157341 human embryonic stem cells differentiated toan early endodermal cell type .a 181 to 917 1 to 737       737/737
(100 %)
0 diff
(100 %id)
BQ214144 embryonal carcinoma, cell line, testis .a 183 to 866 1 to 684       684/931
(73 %)
11 diff
(98.9 %id)
DA983884 synovial membrane tissue from rheumatioidarthritis .a 187 to 745 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP354439   .a 189 to 771 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB265146 uterus .a 189 to 668 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
BP213126 cerebrum .a 190 to 764 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BP231318 muscle .a 190 to 771 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP232491 muscle .a 190 to 773 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BP245117 Kidney .a 190 to 771 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CB135860 Liver .a 190 to 668 1 to 479       479/479
(100 %)
0 diff
(100 %id)
BP288449 lung .a 190 to 772 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP289967 lung .a 190 to 770 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
AU280448   .a 190 to 764 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BP353404   .a 190 to 772 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP354710   .a 190 to 771 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB024346 testis .a 190 to 747 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA001246   .a 191 to 702 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA001556   .a 191 to 757 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA013293 adrenal gland .a 191 to 783 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
BC067225 Testis, embryonal carcinoma .a 191 to 1845 1 to 1655   available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1655/1655
(100 %)
3 diff
(99.9 %id)
DA053128   .a 191 to 765 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA105583 cerebellum .a 191 to 785 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA264213 caudate nucleus .a 191 to 740 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA385890 thalamus .a 191 to 738 2 to 549   capped   548/557
(98 %)
1 diff
(99.9 %id)
DA421739 cervix .a 191 to 755 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA462421 cord Blood .a 191 to 921 2 to 737   capped   736/797
(92 %)
9 diff
(98.9 %id)
DA534629 heart .a 191 to 764 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA547809   .a 191 to 512 2 to 323   capped   322/322
(100 %)
0 diff
(100 %id)
DA549374   .a 191 to 765 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA559334   .a 191 to 689 2 to 501   capped   500/500
(100 %)
2 diff
(99.6 %id)
AU118782 whole embryo, mainly head .a 191 to 1014 2 to 830   capped   829/831
(99 %)
15 diff
(98.2 %id)
DA573719   .a 191 to 739 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA574813   .a 191 to 737 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA575361   .a 191 to 759 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA576649   .a 191 to 484 2 to 295   capped   294/294
(100 %)
0 diff
(100 %id)
DA579430   .a 191 to 741 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA582330 lung .a 191 to 749 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA585416 lung .a 191 to 739 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA598074   .a 191 to 741 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA600677   .a 191 to 758 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA600710   .a 191 to 762 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA601142   .a 191 to 770 2 to 584   capped   583/583
(100 %)
4 diff
(99.4 %id)
BU600189 mixed (pool of 40 RNAs) .a 191 to 921 1 to 740       740/794
(93 %)
26 diff
(96.8 %id)
DA649019   .a 191 to 427 2 to 238   capped   237/237
(100 %)
0 diff
(100 %id)
DA657899   .a 191 to 596 2 to 407   capped   406/406
(100 %)
1 diff
(99.8 %id)
DA663425   .a 191 to 754 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA669108 esophagus .a 191 to 670 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
DA683504   .a 191 to 689 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
DA693997   .a 191 to 711 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
AU131507   .a 191 to 1014 2 to 829   capped   828/828
(100 %)
8 diff
(99.1 %id)
AU132403   .a 191 to 896 2 to 710   capped   709/709
(100 %)
9 diff
(98.8 %id)
DA884172   .a 191 to 748 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA914115   .a 191 to 764 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA916938 small intestine .a 191 to 747 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA919279 small intestine .a 191 to 691 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA920924 small intestine .a 191 to 748 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA926461 small intestine .a 191 to 691 2 to 502   capped   501/501
(100 %)
1 diff
(99.9 %id)
DA972228 synovial membrane tissue from rheumatioidarthritis .a 191 to 772 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA975174 synovial membrane tissue from rheumatioidarthritis .a 191 to 753 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA975484 synovial membrane tissue from rheumatioidarthritis .a 191 to 721 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DB244368 uterus, tumor tissue .a 191 to 750 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB246204 uterus, tumor tissue .a 191 to 768 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DB250275 uterus .a 191 to 689 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DB252575 uterus .a 191 to 640 2 to 451   capped   450/450
(100 %)
0 diff
(100 %id)
DB253808 uterus .a 191 to 670 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
DB259120 uterus .a 191 to 767 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB262387 uterus .a 191 to 764 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB264052 uterus .a 191 to 776 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DB271612 uterus .a 191 to 638 2 to 451   capped   450/450
(100 %)
2 diff
(99.6 %id)
BP353952   .a 192 to 772 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA046722 bladder .a 193 to 646 2 to 456   capped   455/464
(98 %)
2 diff
(99.6 %id)
DA452444 tongue, tumor tissue .a 193 to 752 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP268529 thyroid .a 194 to 774 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP339846 Spleen .a 194 to 764 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DA001201   .a 195 to 722 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA007664   .a 195 to 731 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA045370 bladder .a 195 to 774 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA373356 thalamus .a 195 to 755 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA682191 ovary .a 195 to 766 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
AU126156   .a 195 to 734 2 to 541   capped   540/540
(100 %)
6 diff
(98.9 %id)
DA964060 stomach .a 195 to 742 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA970168 stomach .a 195 to 761 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BP319498 pericardium .a 196 to 778 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA882778   .a 196 to 448 2 to 254   capped   253/253
(100 %)
0 diff
(100 %id)
DA474801   .a 197 to 768 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA966728 stomach .a 197 to 747 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA378408 thalamus .a 198 to 805 2 to 610   capped   609/609
(100 %)
1 diff
(99.9 %id)
DA480557   .a 198 to 757 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP280005   .a 198 to 791 1 to 593       593/593
(100 %)
0 diff
(100 %id)
DA265714 caudate nucleus .a 199 to 775 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA598582   .a 199 to 766 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA605597   .a 199 to 813 2 to 616   capped   615/615
(100 %)
0 diff
(100 %id)
DB234455 trachea .a 199 to 638 2 to 441   capped   440/440
(100 %)
0 diff
(100 %id)
DB244310 uterus, tumor tissue .a 199 to 750 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA578660   .a 200 to 743 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BF026361 melanotic melanoma, skin .a 200 to 1010 1 to 805       805/1007
(79 %)
15 diff
(98.6 %id)
BQ898783 brain, neuroblastoma, cell line .a 206 to 1134 1 to 930       930/930
(100 %)
9 diff
(99.1 %id)
CX760318 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 206 to 922 1 to 707     Submitted on the opposite strand 709/815
(86 %)
13 diff
(98.5 %id)
DB245782 uterus, tumor tissue .a 207 to 784 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA539806 Kidney .a 210 to 805 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
X05276   .a 210 to 2259 1 to 2049   tiling clone,   2049/2049
(100 %)
2 diff
(100.0 %id)
DA006662   .a 211 to 787 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA599307   .a 211 to 775 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
BM463637 leiomyosarcoma, uterus .a 212 to 1260 32 to 1098       1065/1099
(96 %)
52 diff
(95.3 %id)
BC002827 Placenta, choriocarcinoma .a 213 to 1999 1 to 1788   available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1788/1788
(100 %)
2 diff
(99.9 %id)
CB268311 adipose .a 213 to 559 1 to 348       348/348
(100 %)
1 diff
(99.8 %id)
BU149342 epidermoid carcinoma, cell line, lung .a 213 to 963 1 to 759       757/969
(78 %)
8 diff
(99.2 %id)
BM462403 leiomyosarcoma, uterus .a 214 to 1061 1 to 859       855/1070
(79 %)
31 diff
(97.2 %id)
AK315076 tongue .a 216 to 1007 1 to 792       792/792
(100 %)
0 diff
(100 %id)
BQ712716 Spleen .a 216 to 1013 1 to 808       808/906
(89 %)
18 diff
(98.1 %id)
BQ706675 Spleen .a 216 to 1122 1 to 914       912/914
(99 %)
19 diff
(98.0 %id)
BQ710207 Spleen .a 216 to 958 1 to 747       745/844
(88 %)
19 diff
(97.8 %id)
DB028109 testis .a 216 to 742 2 to 530   capped   529/529
(100 %)
3 diff
(99.5 %id)
DA765573 tongue .a 217 to 775 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB241985 stomach, tumor tissue .a 217 to 778 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB246983   .a 217 to 768 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CN275208 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 219 to 920 1 to 702       702/702
(100 %)
0 diff
(100 %id)
DA431403 colon .a 221 to 638 2 to 419   capped   418/418
(100 %)
0 diff
(100 %id)
AL558831 T cells from T cell leukemia .a 228 to 1171 1 to 944       944/944
(100 %)
10 diff
(99.0 %id)
BE407241 choriocarcinoma, placenta .a 231 to 924 1 to 695       695/721
(96 %)
9 diff
(98.8 %id)
BM754276 stomach .a 233 to 595 1 to 361       361/361
(100 %)
5 diff
(98.7 %id)
BP280766   .a 238 to 820 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA688322   .a 238 to 788 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP321196 placenta .a 238 to 821 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DA075917 cerebellum .a 239 to 794 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA503539 brain .a 239 to 828 2 to 595   capped   591/594
(99 %)
8 diff
(98.7 %id)
BE905960 epithelioid carcinoma, Pancreas .a 245 to 832 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
CN275204 embryonic stem cells, DMSO-treated H9 cellline .a 246 to 559 1 to 314       314/314
(100 %)
3 diff
(99.1 %id)
AF310722 anaplastic large cell lymphoma .a 255 to 924 1 to 670       670/966
(69 %)
1 diff
(99.9 %id)
AF186109   .a 258 to 924 1 to 667       667/716
(93 %)
1 diff
(99.9 %id)
TI_1948101073   .a 260 to 557 128 to 425   fully sequenced,   298/326
(91 %)
7 diff
(97.9 %id)
TI_1948101497   .a 260 to 1011 128 to 882       755/1345
(56 %)
39 diff
(97.2 %id)
BT019634   .a 261 to 1006 1 to 746       746/747
(99 %)
1 diff
(99.9 %id)
CV026292 mixed .a 261 to 859 1 to 598       598/602
(99 %)
10 diff
(98.4 %id)
CV030841 mixed .a 261 to 890 1 to 630       630/634
(99 %)
1 diff
(99.9 %id)
BI861759 breast, mammary adenocarcinoma, cell line .a 272 to 1131 1 to 858       858/866
(99 %)
13 diff
(98.5 %id)
TI_57193146   .a 272 to 1131 51 to 908       858/866
(99 %)
13 diff
(98.5 %id)
BE393287 endometrium, adenocarcinoma cell line, uterus .a 275 to 767 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BM464266 leiomyosarcoma, uterus .a 285 to 1296 1 to 1019       1019/1073
(94 %)
26 diff
(97.6 %id)
CA407308 adipose .a 301 to 631 1 to 331       331/331
(100 %)
1 diff
(99.7 %id)
CN275206 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 303 to 507 1 to 205       205/205
(100 %)
0 diff
(100 %id)
AW939269 denis_drash .a 351 to 802 1 to 452       452/452
(100 %)
0 diff
(100 %id)
DA617125   .a 354 to 941 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
TI_1948101074   .a 496 to 1011 631 to 116   fully sequenced,   516/631
(81 %)
0 diff
(100 %id)
AU145266 whole embryo, mainly head .a 1426 to 2002 573 to 1       573/574
(99 %)
6 diff
(99.0 %id)
AL580563 T cells from T cell leukemia .a 1585 to 2564 980 to 1   tiling clone,   980/990
(98 %)
40 diff
(96.0 %id)
DB369299   .a 2219 to 2603 387 to 1       387/389
(99 %)
16 diff
(95.9 %id)
DB368543   .a 2452 to 2662 211 to 1   tiling clone,   211/211
(100 %)
1 diff
(99.6 %id)
AA911569 lung, small cell carcinoma .b-u 1 to 329 31 to 359   tiling clone, Submitted on the opposite strand 329/359
(91 %)
6 diff
(98.4 %id)
AK056565   .b-u 2 to 3104 3108 to 1   tiling clone, available from FLJ, Submitted on the opposite strand 3108/3108
(100 %)
12 diff
(99.7 %id)
DB324938   .b-u 2 to 519 1 to 518   tiling clone, Submitted on the opposite strand 518/518
(100 %)
5 diff
(99.1 %id)
AW882454 ovary .b-u 344 to 643 319 to 19       301/322
(93 %)
0 diff
(100 %id)
BQ430972 embryonal carcinoma, cell line, testis .b-u 558 to 1196 645 to 1     Submitted on the opposite strand 645/954
(67 %)
33 diff
(96.6 %id)
CN289125 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b-u 933 to 1509 579 to 1   tiling clone, Submitted on the opposite strand 579/579
(100 %)
3 diff
(99.5 %id)
DC366579   .b-u 2011 to 2403 1 to 393       393/393
(100 %)
0 diff
(100 %id)
CN346347 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b-u 2618 to 2836 1 to 219       219/219
(100 %)
0 diff
(100 %id)
CN346346 embryonic stem cells, DMSO-treated H9 cellline .b-u 2653 to 3010 1 to 359       359/750
(47 %)
4 diff
(99.5 %id)
CN346345 embryonic stem cells, DMSO-treated H9 cellline .b-u 2714 to 3002 1 to 289   tiling clone,   289/291
(99 %)
1 diff
(99.7 %id)
TI_57238499   .b-u 2724 to 3563 23 to 865       843/865
(97 %)
6 diff
(99.4 %id)
BI913007 brain .b-u 2730 to 3563 1 to 837   tiling clone,   837/837
(100 %)
31 diff
(96.3 %id)
BX102582 pooled .b-u 3017 to 3325 1 to 313       313/315
(99 %)
4 diff
(98.8 %id)
CN264753 embryonic stem cells, cell lines H1, H7, andH9 .b-u 3334 to 4022 25 to 714   tiling clone,   690/714
(96 %)
6 diff
(99.2 %id)
CB164097 Liver .b-u 3392 to 3899 1 to 508   tiling clone,   508/508
(100 %)
0 diff
(100 %id)
BU148979 brain, neuroblastoma, cell line .b-u 3672 to 4567 918 to 12   tiling clone, Submitted on the opposite strand 907/920
(98 %)
31 diff
(96.7 %id)
BI022938 marrow .b-u 3721 to 3953 235 to 2       234/235
(99 %)
0 diff
(100 %id)
BI022943 marrow .b-u 3721 to 3952 234 to 4       231/234
(98 %)
0 diff
(100 %id)
BY797095 eye .b-u 3750 to 4414 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
BF380107 uterus_tumor .b-u 3786 to 3931 165 to 20       146/165
(88 %)
0 diff
(100 %id)
BF380182 uterus_tumor .b-u 3786 to 3923 138 to 1       138/138
(100 %)
0 diff
(100 %id)
BF380136 uterus_tumor .b-u 3787 to 3923 1 to 137       137/137
(100 %)
2 diff
(98.6 %id)
BF380141 uterus_tumor .b-u 3789 to 3923 16 to 150       135/150
(90 %)
6 diff
(96.0 %id)
BM545758 ovary (pool of 3) .b-u 3811 to 4556 53 to 805       753/836
(90 %)
50 diff
(94.1 %id)
BX114634 germinal center B cell .b-u 3878 to 4553 676 to 1     Submitted on the opposite strand 676/676
(100 %)
2 diff
(99.8 %id)
BM995676 Chondrosarcoma, Left Pubic Bone .b-u 3896 to 4557 664 to 1       664/664
(100 %)
3 diff
(99.6 %id)
BM475617 embryonal carcinoma, cell line, testis .b-u 3968 to 4558 1 to 591       591/1135
(52 %)
5 diff
(99.6 %id)
BM726051 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b-u 3985 to 4539 1 to 555   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 555/555
(100 %)
0 diff
(100 %id)
BQ321884 colon .b-u 4005 to 4356 37 to 392       356/394
(90 %)
6 diff
(98.5 %id)
FN139007 breast carcinoma .b-u 4039 to 4105 68 to 2     Submitted on the opposite strand 67/69
(97 %)
0 diff
(100 %id)
AI972661 Prostate .b-u 4046 to 4539 494 to 1       494/494
(100 %)
0 diff
(100 %id)
BQ314525 breast_normal .b-u 4068 to 4535 470 to 2       469/492
(95 %)
0 diff
(100 %id)
BF590541 colon, colon tumor, RER+ .b-u 4075 to 4539 465 to 1       465/465
(100 %)
0 diff
(100 %id)
CN276750 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b-u 4105 to 4426 1 to 322       322/322
(100 %)
4 diff
(98.8 %id)
BE677627 dorsal root ganglia .b-u 4109 to 4541 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AA812278 invasive tumor (cell line), Prostate .b-u 4111 to 4546 436 to 1       436/436
(100 %)
7 diff
(98.4 %id)
BF848023 lung_normal .b-u 4130 to 4460 361 to 29     Submitted on the opposite strand 333/365
(91 %)
11 diff
(97.0 %id)
BF925490 nervous_tumor .b-u 4130 to 4528 409 to 11     Submitted on the opposite strand 399/411
(97 %)
0 diff
(100 %id)
BG004094 placenta_normal .b-u 4130 to 4528 409 to 11       399/411
(97 %)
0 diff
(100 %id)
AA578828 lung, lung tumor .b-u 4135 to 4542 407 to 1       407/407
(100 %)
3 diff
(99.3 %id)
AI168563 liver and spleen .b-u 4143 to 4539 395 to 1       395/395
(100 %)
5 diff
(98.8 %id)
AA459600 germinal center B cell .b-u 4147 to 4539 392 to 1     Submitted on the opposite strand 392/392
(100 %)
2 diff
(99.5 %id)
BF871870 lung_tumor .b-u 4149 to 4533 1 to 392       392/398
(98 %)
33 diff
(91.8 %id)
AI984322 Kidney .b-u 4149 to 4539 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AW968668   .b-u 4157 to 4538 382 to 1     Submitted on the opposite strand 382/382
(100 %)
8 diff
(98.0 %id)
AA564489   .b-u 4305 to 4555 252 to 1       252/252
(100 %)
4 diff
(98.5 %id)
BE836553 prostate_normal .b-u 4336 to 4613 11 to 289       279/289
(96 %)
6 diff
(98.0 %id)
BQ347104 nervous_tumor .b-u 4354 to 4498 25 to 168       144/168
(85 %)
6 diff
(96.5 %id)
BI038569 nervous_tumor .b-u 4364 to 4813 461 to 2       460/461
(99 %)
0 diff
(100 %id)
BI042252 nervous_tumor .b-u 4364 to 4897 1 to 538       538/540
(99 %)
40 diff
(92.6 %id)
BI042283 nervous_tumor .b-u 4377 to 4797 478 to 57   tiling clone,   422/521
(80 %)
0 diff
(100 %id)
FN162105 breast carcinoma .b-u 4380 to 4501 1 to 121       121/121
(100 %)
1 diff
(99.2 %id)
BI042322 nervous_tumor .b-u 4403 to 4891 513 to 26       488/513
(95 %)
0 diff
(100 %id)
FN091351 breast carcinoma .b-u 4427 to 4537 1 to 108       108/110
(98 %)
4 diff
(96.4 %id)
BG272721 nasopharynx, normal epithelium .b-u 4454 to 4545 98 to 7       92/98
(93 %)
0 diff
(100 %id)
BX119709 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b-u 4560 to 4985 440 to 15   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 426/426
(100 %)
0 diff
(100 %id)
AK096732 placenta .b-u 4561 to 6517 1 to 1957   tiling clone, available from FLJ,   1957/1957
(100 %)
19 diff
(99.1 %id)
DA847085 placenta .b-u 4562 to 5120 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA179623 amygdala .b-u 4643 to 5133 2 to 493   capped   492/492
(100 %)
1 diff
(99.8 %id)
BF853717 lung_normal .b-u 4665 to 4955 293 to 3     Submitted on the opposite strand 291/295
(98 %)
0 diff
(100 %id)
AI539811 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b-u 4737 to 5140 404 to 1   tiling clone,   404/404
(100 %)
1 diff
(99.8 %id)
AI610471 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b-u 4738 to 4987 250 to 1       250/250
(100 %)
0 diff
(100 %id)
BF355190 head_neck .b-u 4750 to 4860 112 to 1       112/112
(100 %)
2 diff
(98.3 %id)
BQ372417 prostate_normal .b-u 4785 to 5024 258 to 22       237/273
(86 %)
0 diff
(100 %id)
DW443693 Liver .b-u 4788 to 5000 17 to 229       213/229
(93 %)
6 diff
(97.4 %id)
DW464384 Liver .b-u 4788 to 4876 17 to 105       89/105
(84 %)
6 diff
(94.3 %id)
T41325   .b-u 4965 to 5258 26 to 319       294/319
(92 %)
6 diff
(98.2 %id)
BE714591 head_neck .b-u 5006 to 5260 1 to 257       257/257
(100 %)
5 diff
(98.1 %id)
CN357239 embryonic stem cells, DMSO-treated H9 cellline .b-u 5179 to 5738 4 to 563   tiling clone,   560/563
(99 %)
6 diff
(99.0 %id)
AW949300 prostate_tumor .b-u 5650 to 5857 1 to 207   tiling clone,   207/207
(100 %)
2 diff
(99.1 %id)
AW949310 prostate_tumor .b-u 5650 to 5866 1 to 218       218/220
(99 %)
7 diff
(96.9 %id)
DW466147 Liver .b-u 5684 to 6020 17 to 353       337/353
(95 %)
6 diff
(98.4 %id)
DW432976 Liver .b-u 5861 to 6107 17 to 264       248/264
(93 %)
6 diff
(97.8 %id)
DW418909 Liver .b-u 5969 to 6364 17 to 412   tiling clone,   396/413
(95 %)
4 diff
(99.1 %id)
DW448719 Liver .b-u 6116 to 6313 9 to 206   tiling clone,   198/206
(96 %)
12 diff
(94.2 %id)
NM_001145160.1   .c 1 to 2627 4 to 2630 exact RefSeq,   2630/2630
(100 %)
0 diff
(100 %id)
DA029675   .c 1 to 572 4 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA032511   .c 1 to 572 4 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA078350 cerebellum .c 1 to 546 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA454490 tongue, tumor tissue .c 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DA079740 cerebellum .c 6 to 533 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA254714 caudate nucleus .c 24 to 585 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL710690 human skeletal muscle .c 26 to 370 1 to 345       345/345
(100 %)
8 diff
(97.7 %id)
DB255708 uterus .c 26 to 601 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA088839 cerebellum .c 28 to 601 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA251894 caudate nucleus .c 29 to 257 2 to 230   capped   229/229
(100 %)
0 diff
(100 %id)
BP329709 rectum .c 29 to 609 1 to 580       580/581
(99 %)
3 diff
(99.5 %id)
BP330241 rectum .c 29 to 616 1 to 588       588/588
(100 %)
0 diff
(100 %id)
DA598663   .c 30 to 586 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA600672   .c 30 to 585 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
BM849970 stomach .c 30 to 582 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BM850968 stomach .c 30 to 479 1 to 450       450/450
(100 %)
0 diff
(100 %id)
DA939456 Spleen .c 30 to 601 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA939715 Spleen .c 30 to 509 2 to 481   capped   480/480
(100 %)
1 diff
(99.8 %id)
DB193688 ovary, tumor tissue .c 30 to 597 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB252137 uterus .c 30 to 603 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
CR599958 HeLa cells Cot 25-normalized .c 38 to 1588 1 to 1551 exact tiling clone,   1551/1551
(100 %)
0 diff
(100 %id)
DA060983 cerebellum .c 40 to 589 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CN264604 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 40 to 412 32 to 403       372/403
(92 %)
6 diff
(98.6 %id)
CN482153 eye .c 42 to 644 1 to 603       603/603
(100 %)
0 diff
(100 %id)
DA078507 cerebellum .c 44 to 621 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BM822605 stomach .c 46 to 378 1 to 333       333/333
(100 %)
1 diff
(99.7 %id)
BM831235 stomach .c 46 to 559 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
BM831839 stomach .c 47 to 337 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
BM832442 stomach .c 63 to 184 1 to 122       122/122
(100 %)
1 diff
(99.2 %id)
AW369411 breast_normal .c 89 to 634 1 to 545       545/545
(100 %)
3 diff
(99.5 %id)
BE002995 breast_normal .c 91 to 428 1 to 338       338/338
(100 %)
6 diff
(98.3 %id)
BE814818 breast_normal .c 104 to 449 1 to 346       346/346
(100 %)
2 diff
(99.5 %id)
DA061805 cerebellum .c 136 to 683 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BP340700 stomach mucosa .c 136 to 741 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BE814805 breast_normal .c 137 to 446 1 to 315       315/315
(100 %)
12 diff
(96.2 %id)
BM829202 Ascites, stomach .c 137 to 735 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
AW580721 leiomios .c 206 to 766 1 to 561       561/561
(100 %)
0 diff
(100 %id)
EL595064 epidermis, skin .c 227 to 649 451 to 33     Submitted on the opposite strand 419/465
(90 %)
7 diff
(98.5 %id)
BM851240 stomach .c 231 to 350 1 to 120       120/120
(100 %)
2 diff
(98.4 %id)
BI859803 breast, mammary adenocarcinoma, cell line .c 269 to 1036 1 to 771       771/772
(99 %)
9 diff
(98.9 %id)
TI_57188875   .c 269 to 1036 49 to 819       771/772
(99 %)
9 diff
(98.9 %id)
AA133943 colon, tumor .c 336 to 722 1 to 391       391/391
(100 %)
4 diff
(99.0 %id)
BF931823 nervous_tumor .c 356 to 524 24 to 192       169/192
(88 %)
1 diff
(99.5 %id)
CN275213 embryonic stem cells, cell lines H1, H7, andH9 .c 356 to 962 12 to 618       607/619
(98 %)
7 diff
(98.9 %id)
TI_1948074186   .c 379 to 974 717 to 122       596/1324
(45 %)
18 diff
(98.7 %id)
BM918103 blood, natural killer cells, cell line .c 425 to 1251 1 to 835       835/1097
(76 %)
15 diff
(98.7 %id)
BF229151 amnion_normal .c 436 to 787 26 to 377       352/379
(92 %)
7 diff
(98.2 %id)
BQ228444 large cell carcinoma, lung .c 437 to 1322 1 to 889       889/889
(100 %)
9 diff
(99.0 %id)
CN275216 embryonic stem cells, cell lines H1, H7, andH9 .c 438 to 1121 1 to 684       684/686
(99 %)
2 diff
(99.8 %id)
BI861668 breast, mammary adenocarcinoma, cell line .c 463 to 1333 1 to 871       871/882
(98 %)
17 diff
(98.1 %id)
TI_57191756   .c 463 to 1333 86 to 956       871/882
(98 %)
17 diff
(98.1 %id)
BG164007 hypernephroma, cell line, Kidney .c 465 to 1289 1 to 812       812/975
(83 %)
67 diff
(93.2 %id)
AA096433   .c 466 to 621 1 to 156       156/156
(100 %)
0 diff
(100 %id)
BM470808 leiomyosarcoma, uterus .c 489 to 1244 1 to 762       762/1098
(69 %)
22 diff
(98.0 %id)
BI857993 breast, mammary adenocarcinoma, cell line .c 500 to 1103 8 to 612       605/614
(98 %)
8 diff
(98.7 %id)
TI_57191188   .c 500 to 1103 132 to 736       605/614
(98 %)
8 diff
(98.7 %id)
BG033912 breast, mammary adenocarcinoma, cell line .c 523 to 1331 1 to 804       804/996
(80 %)
26 diff
(97.4 %id)
BG757280 B-cells, primary B-cells from tonsils (cell line) .c 529 to 1355 1 to 827       827/827
(100 %)
6 diff
(99.3 %id)
BP326754 prostata .c 536 to 1117 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BU598909 mixed (pool of 40 RNAs) .c 563 to 1340 1 to 778       778/781
(99 %)
12 diff
(98.5 %id)
BG030069 breast, mammary adenocarcinoma, cell line .c 571 to 1271 1 to 702       702/1145
(61 %)
25 diff
(97.9 %id)
M12127   .c 573 to 969 1 to 397       397/397
(100 %)
6 diff
(98.5 %id)
TI_154110848   .c 577 to 1273 696 to 3       694/976
(71 %)
3 diff
(99.7 %id)
AA853762 Bone, Hip .c 586 to 885 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
BG773999 choriocarcinoma, placenta .c 602 to 1294 694 to 2     Submitted on the opposite strand 693/694
(99 %)
0 diff
(100 %id)
BF770022 epid_tumor .c 668 to 1009 1 to 342       342/342
(100 %)
0 diff
(100 %id)
BE767564 placenta_normal .c 724 to 1092 1 to 369       369/369
(100 %)
0 diff
(100 %id)
CD357446 Blood vessels - aorta, basilar and artery .c 735 to 1410 1 to 689       689/792
(86 %)
17 diff
(97.9 %id)
AW361062 colon .c 738 to 982 245 to 1       245/245
(100 %)
0 diff
(100 %id)
BE789940 large cell carcinoma, lung .c 763 to 1496 1 to 733       733/735
(99 %)
6 diff
(99.2 %id)
AW366497 head_neck .c 767 to 920 1 to 153       153/154
(99 %)
4 diff
(97.5 %id)
AU134264 ovary, tumor tissue .c 768 to 1446 2 to 681   capped   680/680
(100 %)
3 diff
(99.6 %id)
BF218452 brain, glioblastoma .c 775 to 1507 1 to 724       724/857
(84 %)
36 diff
(95.8 %id)
CN275209 embryonic stem cells, cell lines H1, H7, andH9 .c 776 to 1346 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
TI_149308053   .c 788 to 1367 712 to 133       580/1065
(54 %)
5 diff
(99.6 %id)
BG283034 adenocarcinoma, cell line, Prostate .c 809 to 1485 1 to 681       681/1142
(59 %)
13 diff
(98.9 %id)
BF792911 adrenal cortex carcinoma, cell line, adrenal gland .c 886 to 1633 12 to 756       745/918
(81 %)
16 diff
(98.3 %id)
AA149500 uterus .c 889 to 1034 1 to 146       146/148
(98 %)
4 diff
(97.3 %id)
T28637 gallbladder .c 929 to 1140 1 to 212       212/212
(100 %)
0 diff
(100 %id)
BM848731 stomach .c 970 to 1536 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BM849032 stomach .c 970 to 1514 1 to 545       545/545
(100 %)
0 diff
(100 %id)
AI699637 pooled germ cell tumors .c 983 to 1120 155 to 18   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 138/138
(100 %)
0 diff
(100 %id)
BQ929282 leiomyosarcoma, uterus .c 986 to 1722 1 to 742       742/911
(81 %)
6 diff
(99.4 %id)
CN275211 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1016 to 1727 8 to 712       705/712
(99 %)
6 diff
(99.2 %id)
BM820916 stomach .c 1021 to 1546 1 to 526       526/526
(100 %)
0 diff
(100 %id)
BG282484 adenocarcinoma, cell line, Prostate .c 1110 to 1927 1 to 811       811/945
(85 %)
36 diff
(96.2 %id)
BG576129 breast, mammary adenocarcinoma, cell line .c 1134 to 1971 1 to 844       844/854
(98 %)
14 diff
(98.4 %id)
BG333110 large cell carcinoma, lung .c 1178 to 1932 1 to 757       757/757
(100 %)
14 diff
(98.2 %id)
BP340132 Spleen .c 1222 to 1802 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN275221 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1274 to 1915 1 to 641       641/641
(100 %)
2 diff
(99.7 %id)
TI_59394287   .c 1292 to 1896 58 to 669       612/612
(100 %)
19 diff
(96.9 %id)
BP338944 Spleen .c 1312 to 1893 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN275220 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1318 to 2079 1 to 762       762/762
(100 %)
2 diff
(99.8 %id)
BQ005639 Chondrosarcoma, Left Pubic Bone .c 1327 to 1992 682 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 664/664
(100 %)
3 diff
(99.6 %id)
CN275205 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1329 to 1971 1 to 643       643/644
(99 %)
1 diff
(99.9 %id)
BM509075 insulinoma, Pancreas .c 1374 to 1965 607 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 592/592
(100 %)
0 diff
(100 %id)
BM875323 insulinoma, Pancreas .c 1376 to 1965 605 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 590/590
(100 %)
0 diff
(100 %id)
BU782976 insulinoma, Pancreas .c 1386 to 1965 595 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 580/580
(100 %)
0 diff
(100 %id)
BU786736 insulinoma, Pancreas .c 1387 to 1965 593 to 15   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
BJ992604 hepatoblastoma .c 1395 to 1772 378 to 1       378/379
(99 %)
1 diff
(99.8 %id)
AW511633 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1395 to 1808 414 to 1       414/414
(100 %)
0 diff
(100 %id)
DC426398.
matches multiple genes
brain .c 1409 to 1965 558 to 1     also hits gene renima 558/558
(100 %)
1 diff
(99.9 %id)
AA128749   .c 1411 to 1676 1 to 275   fully sequenced,   275/275
(100 %)
0 diff
(100 %id)
DR421942 eye, Pterygium .c 1460 to 2166 1 to 706   tiling clone,   706/706
(100 %)
1 diff
(99.9 %id)
BG117002 duodenal adenocarcinoma, cell line, small intestine .c 1470 to 2173 1 to 701       701/955
(73 %)
13 diff
(98.7 %id)
BP390833 pancreatic islet .c 1473 to 1965 1 to 493     Submitted on the opposite strand 493/493
(100 %)
0 diff
(100 %id)
BQ420588 embryonal carcinoma, cell line, testis .c 1483 to 1962 1 to 480   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
BF326057 amnion_normal .c 1492 to 1691 1 to 200       200/200
(100 %)
0 diff
(100 %id)
CN275202 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1499 to 2215 1 to 718       718/718
(100 %)
8 diff
(98.9 %id)
AW173716 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1500 to 1962 463 to 1       463/463
(100 %)
0 diff
(100 %id)
BU947634 insulinoma, Pancreas .c 1512 to 1965 469 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 454/454
(100 %)
0 diff
(100 %id)
AI744235 ovary, tumor, 5 pooled (see description) .c 1533 to 1971 441 to 3       439/441
(99 %)
0 diff
(100 %id)
AW008376 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1533 to 1965 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AA070946   .c 1540 to 1963 1 to 428   fully sequenced,   428/428
(100 %)
5 diff
(98.9 %id)
AI587345 adenocarcinoma, Pancreas .c 1558 to 1965 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AW419166 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1561 to 1962 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI750914 Bone, Hip .c 1561 to 1939 386 to 8       379/386
(98 %)
0 diff
(100 %id)
AI087249 senescent fibroblast .c 1563 to 2001 445 to 7       439/445
(98 %)
0 diff
(100 %id)
AI245925 adenocarcinoma, colon .c 1593 to 1992 400 to 1       400/400
(100 %)
0 diff
(100 %id)
CA392344 eye, RPE/choroid .c 1615 to 1991 1 to 377       377/377
(100 %)
0 diff
(100 %id)
AA128676   .c 1646 to 1995 354 to 1   fully sequenced,   354/354
(100 %)
8 diff
(97.8 %id)
BG032951 breast, mammary adenocarcinoma, cell line .c 1648 to 2466 9 to 821       813/901
(90 %)
19 diff
(97.9 %id)
CB159522 Liver .c 1679 to 2238 560 to 1     Submitted on the opposite strand 560/560
(100 %)
0 diff
(100 %id)
N21038 melanocyte .c 1716 to 2267 552 to 1       552/552
(100 %)
9 diff
(98.4 %id)
AA070947   .c 1727 to 1963 237 to 1   fully sequenced,   237/237
(100 %)
2 diff
(99.2 %id)
BX476508   .c 1733 to 2291 1 to 559       559/559
(100 %)
0 diff
(100 %id)
DR157020 human embryonic stem cells differentiated toan early endodermal cell type .c 1752 to 2534 1 to 783       783/783
(100 %)
0 diff
(100 %id)
BY993986   .c 1782 to 2409 1 to 628       628/628
(100 %)
7 diff
(98.9 %id)
BP337582 coronary artery .c 1814 to 2371 1 to 558       558/561
(99 %)
8 diff
(98.6 %id)
CN275210 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1833 to 2505 9 to 680       672/680
(98 %)
6 diff
(99.2 %id)
AA088652.
matches multiple genes
uterus .c 1870 to 2308 12 to 451     Suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene snoyzor 440/451
(97 %)
6 diff
(98.7 %id)
AA043825 uterus .c 1871 to 2240 1 to 372   fully sequenced,   372/372
(100 %)
1 diff
(99.8 %id)
BY993773   .c 1878 to 2505 644 to 17     Submitted on the opposite strand 628/644
(97 %)
0 diff
(100 %id)
BE083124 breast .c 1888 to 2473 7 to 591       585/604
(96 %)
9 diff
(98.6 %id)
AW361561 colon .c 1889 to 2457 574 to 3       572/581
(98 %)
0 diff
(100 %id)
AW361714 colon .c 1889 to 2444 561 to 6       556/570
(97 %)
0 diff
(100 %id)
AW361809 colon .c 1889 to 2468 8 to 587       580/589
(98 %)
6 diff
(99.0 %id)
AW370643 breast .c 1889 to 2464 576 to 3       574/583
(98 %)
0 diff
(100 %id)
BQ428493 leiomyosarcoma, uterus .c 1893 to 2510 11 to 634       624/997
(62 %)
14 diff
(98.6 %id)
AW361849 colon .c 1896 to 2459 1 to 564       564/575
(98 %)
6 diff
(99.0 %id)
BU954939 mixed (pool of 40 RNAs) .c 1926 to 2550 1 to 628       628/797
(78 %)
5 diff
(99.4 %id)
BU533080 mixed (pool of 40 RNAs) .c 1940 to 2624 1 to 686       686/825
(83 %)
9 diff
(99.0 %id)
BF335403 colon .c 1944 to 2414 471 to 1       471/473
(99 %)
2 diff
(99.6 %id)
BF335470 colon .c 1944 to 2414 1 to 471       471/471
(100 %)
4 diff
(99.2 %id)
AW378536 head_neck .c 1962 to 2462 1 to 501       501/546
(91 %)
7 diff
(98.8 %id)
AW378541 head_neck .c 1962 to 2436 477 to 3       475/558
(85 %)
0 diff
(100 %id)
BI044450 ovary .c 1964 to 2180 1 to 217       217/217
(100 %)
0 diff
(100 %id)
BQ369298 placenta_normal .c 1964 to 2474 509 to 3       507/509
(99 %)
0 diff
(100 %id)
AW378535 head_neck .c 1975 to 2417 444 to 1       444/446
(99 %)
10 diff
(97.8 %id)
BQ304283 breast .c 1984 to 2425 9 to 452       444/452
(98 %)
6 diff
(98.7 %id)
AI620610 Prostate .c 1990 to 2269 300 to 21   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 280/280
(100 %)
3 diff
(99.0 %id)
BG575596 breast, mammary adenocarcinoma, cell line .c 2008 to 2602 1 to 594       594/795
(74 %)
5 diff
(99.4 %id)
AW797453 uterus .c 2013 to 2419 409 to 2       408/409
(99 %)
0 diff
(100 %id)
AA775705 heart .c 2022 to 2565 544 to 1       544/544
(100 %)
3 diff
(99.5 %id)
BE693225 breast .c 2034 to 2414 389 to 9       381/389
(97 %)
0 diff
(100 %id)
BF330657 breast .c 2034 to 2396 367 to 5       363/367
(98 %)
0 diff
(100 %id)
AA639664 colon, colon tumor RER+ .c 2034 to 2566 533 to 1   tiling clone,   533/533
(100 %)
0 diff
(100 %id)
BF912006 uterus_tumor .c 2045 to 2468 427 to 4     Submitted on the opposite strand 424/427
(99 %)
0 diff
(100 %id)
BE162833 head_neck .c 2048 to 2480 434 to 3     Submitted on the opposite strand 432/434
(99 %)
0 diff
(100 %id)
AW390710 stomach .c 2058 to 2462 1 to 405       405/405
(100 %)
3 diff
(99.3 %id)
AW795938 uterus .c 2062 to 2375 319 to 7       313/319
(98 %)
0 diff
(100 %id)
BF853120 lung_normal .c 2063 to 2386 326 to 3     Submitted on the opposite strand 324/326
(99 %)
0 diff
(100 %id)
DB371894 ovary, tumor tissue .c 2070 to 2625 556 to 1       556/559
(99 %)
18 diff
(96.8 %id)
CN275217 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2076 to 2340 1 to 265       265/265
(100 %)
0 diff
(100 %id)
AI185232 lung .c 2086 to 2567 489 to 6       484/489
(98 %)
0 diff
(100 %id)
BQ292517 amnion_normal .c 2093 to 2509 426 to 9       418/426
(98 %)
0 diff
(100 %id)
AI679593 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2095 to 2551 460 to 4       457/460
(99 %)
0 diff
(100 %id)
BQ356106 head_neck .c 2115 to 2368 256 to 3       254/256
(99 %)
0 diff
(100 %id)
AW938708 denis_drash .c 2130 to 2474 342 to 1     Submitted on the opposite strand 342/350
(97 %)
7 diff
(98.0 %id)
AI831033 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 2140 to 2565 426 to 1       426/426
(100 %)
3 diff
(99.3 %id)
AW385929 leiomios .c 2157 to 2331 1 to 175       175/175
(100 %)
4 diff
(97.8 %id)
BI010138 leiomios .c 2159 to 2338 178 to 1       178/178
(100 %)
2 diff
(98.9 %id)
BF365316 nervous_tumor .c 2174 to 2442 9 to 275       267/275
(97 %)
6 diff
(97.9 %id)
AW579118 denis_drash .c 2187 to 2430 1 to 243       243/245
(99 %)
6 diff
(97.6 %id)
AW935501 denis_drash .c 2189 to 2412 226 to 3     Submitted on the opposite strand 224/226
(99 %)
0 diff
(100 %id)
AW935525 denis_drash .c 2189 to 2430 1 to 241       241/251
(96 %)
3 diff
(98.9 %id)
BQ293284 amnion_normal .c 2192 to 2458 268 to 2       267/268
(99 %)
0 diff
(100 %id)
AW935591 denis_drash .c 2198 to 2462 1 to 264       264/264
(100 %)
5 diff
(98.2 %id)
AA043959 uterus .c 2210 to 2558 349 to 1   fully sequenced,   349/349
(100 %)
0 diff
(100 %id)
BF915101 uterus_tumor .c 2231 to 2501 271 to 1     Submitted on the opposite strand 271/272
(99 %)
5 diff
(98.2 %id)
BU532700 mixed (pool of 40 RNAs) .c 2233 to 2634 19 to 420   tiling clone,   402/449
(89 %)
6 diff
(98.7 %id)
BF835526 head_neck .c 2239 to 2501 263 to 1     Submitted on the opposite strand 263/263
(100 %)
0 diff
(100 %id)
BF912962 uterus_tumor .c 2239 to 2506 1 to 267       267/277
(96 %)
3 diff
(99.0 %id)
BF915912 uterus_tumor .c 2239 to 2386 1 to 148       148/148
(100 %)
0 diff
(100 %id)
BF929341 nervous_tumor .c 2241 to 2456 1 to 216       216/216
(100 %)
2 diff
(99.1 %id)
BQ327166 colon_normal .c 2270 to 2486 220 to 4       217/220
(98 %)
0 diff
(100 %id)
BF333504 colon_normal .c 2276 to 2504 230 to 2       229/230
(99 %)
0 diff
(100 %id)
AW938952 denis_drash .c 2280 to 2511 1 to 233       233/233
(100 %)
3 diff
(98.8 %id)
BE162881 head_neck .c 2280 to 2489 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
BF333500 colon_normal .c 2280 to 2502 223 to 1       223/223
(100 %)
3 diff
(98.7 %id)
BQ327165 colon_normal .c 2280 to 2481 202 to 2       201/202
(99 %)
0 diff
(100 %id)
BE073620 breast .c 2286 to 2502 217 to 1     Submitted on the opposite strand 217/217
(100 %)
0 diff
(100 %id)
AW577887 colon_normal .c 2298 to 2486 1 to 188       188/188
(100 %)
2 diff
(99.0 %id)
BF360581 ovary .c 2307 to 2462 153 to 1       153/153
(100 %)
2 diff
(98.7 %id)
BF360584 ovary .c 2307 to 2474 170 to 2       169/170
(99 %)
0 diff
(100 %id)
AW795600 uterus .c 2312 to 2530 1 to 219       219/219
(100 %)
8 diff
(96.4 %id)
AW995963 breast_normal .c 2312 to 2492 194 to 17     Submitted on the opposite strand 178/194
(91 %)
0 diff
(100 %id)
CA311825 Human Lung Epithelial cells, lung .c 2323 to 2593 3 to 273   AAA Submitted on the opposite strand 271/279
(97 %)
6 diff
(97.9 %id)
DA071434 cerebellum .d 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
DA066804 cerebellum .d 142 to 707 2 to 567   tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
CX783065 human embryonic stem cells .d 673 to 1378 735 to 30   tiling clone, AAA Submitted on the opposite strand 706/706
(100 %)
3 diff
(99.6 %id)
DA663180   .e 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
BM465163 eye, retinoblastoma .e 102 to 672 91 to 667       577/978
(58 %)
12 diff
(98.8 %id)
AF186110   .e 208 to 802 1 to 595   tiling clone,   595/883
(67 %)
1 diff
(99.9 %id)
DA590890 lung .f 1 to 557 2 to 558 R123C tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DB292396 uterus .g 1 to 565 8 to 573 E25G D26R R27P A28R Q29A ... capped   572/572
(100 %)
1 diff
(99.9 %id)
DA440501 tongue, tumor tissue .g 1 to 592 4 to 595 exact tiling clone, capped   594/594
(100 %)
0 diff
(100 %id)
BF850018 lung_normal .g 357 to 863 1 to 507   tiling clone,   507/518
(97 %)
4 diff
(99.3 %id)
BF850020 lung_normal .g 357 to 758 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
BE930699 placenta_normal .h 1 to 380 35 to 411   tiling clone,   377/454
(83 %)
7 diff
(98.5 %id)
CN275219 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 66 to 700 1 to 635 exact tiling clone,   635/636
(99 %)
1 diff
(99.9 %id)
CN266202 embryonic stem cells, cell lines H1, H7, andH9 .i-u 1 to 184 1 to 184   tiling clone,   184/184
(100 %)
0 diff
(100 %id)
BF799068 colon_ins .i-u 74 to 285 211 to 2     Submitted on the opposite strand 210/217
(96 %)
0 diff
(100 %id)
AW814580 stomach .i-u 149 to 531 383 to 2       382/383
(99 %)
0 diff
(100 %id)
AK125191 brain .i-u 175 to 2846 1 to 2675 exact tiling clone, available from FLJ,   2675/2675
(100 %)
7 diff
(99.8 %id)
DA518606 brain .i-u 176 to 732 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA205110 brain .i-u 262 to 839 2 to 579   tiling clone, capped   578/578
(100 %)
2 diff
(99.7 %id)
DA486546 brain .i-u 885 to 1440 2 to 560   tiling clone, capped   559/559
(100 %)
4 diff
(99.3 %id)
DA940344 Spleen .i-u 898 to 1421 2 to 527   capped   526/526
(100 %)
5 diff
(99.1 %id)
AA547976 adrenal adenoma, adrenal gland .j-u 1 to 406 406 to 1   tiling clone,   406/406
(100 %)
0 diff
(100 %id)
AI640679 adenocarcinoma, Pancreas .j-u 22 to 408 387 to 1       387/387
(100 %)
0 diff
(100 %id)
CN413311 embryonic stem cells, cell lines H1, H7, andH9 .j-u 369 to 675 93 to 400   tiling clone,   308/400
(77 %)
12 diff
(97.0 %id)
AW850580 colon .j-u 417 to 550 139 to 5   tiling clone,   135/139
(97 %)
0 diff
(100 %id)
AW390093 stomach .j-u 432 to 891 476 to 12   tiling clone,   465/476
(97 %)
0 diff
(100 %id)
AI940726 stomach .j-u 518 to 1088 568 to 3   tiling clone,   566/604
(93 %)
0 diff
(100 %id)
BI043908 ovary .j-u 637 to 856 235 to 22   tiling clone,   214/235
(91 %)
0 diff
(100 %id)
BF746177 breast .j-u 878 to 1243 1 to 367   tiling clone,   367/368
(99 %)
2 diff
(99.5 %id)
CN292992 embryonic stem cells, DMSO-treated H9 cellline .j-u 894 to 1324 1 to 431       431/431
(100 %)
5 diff
(98.9 %id)
CA394473 eye, RPE/choroid .j-u 926 to 1514 1 to 589 exact tiling clone,   589/589
(100 %)
1 diff
(99.9 %id)
AA369615 placenta .j-u 1278 to 1493 1 to 215       215/215
(100 %)
2 diff
(99.1 %id)
BG035599 adenocarcinoma, cell line, Liver .k 1 to 750 1 to 744 Y4C P32H R33G C35A R36E ... tiling clone,   744/817
(91 %)
13 diff
(98.5 %id)
AW850415 colon .k 4 to 490 487 to 1   tiling clone,   487/487
(100 %)
1 diff
(99.8 %id)
BF739031 bladder_tumor .l 1 to 405 405 to 1 exact tiling clone, Submitted on the opposite strand 405/405
(100 %)
6 diff
(98.6 %id)
CD299499 Blood vessels - aorta, basilar and artery .l 37 to 584 1 to 551   tiling clone,   551/752
(73 %)
13 diff
(98.3 %id)
BF737348 bladder_tumor .l 40 to 439 421 to 22     Submitted on the opposite strand 400/421
(95 %)
0 diff
(100 %id)
DA258907 caudate nucleus .m-u 1 to 558 2 to 564 L25F R26F R27E S28T L29E ... tiling clone, capped   563/563
(100 %)
5 diff
(99.2 %id)
BF944789 nervous_normal .m-u 111 to 390 284 to 6   tiling clone, Submitted on the opposite strand 279/288
(96 %)
0 diff
(100 %id)
93 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI